Leading European and international experts will discuss evolving concepts in therapeutics, T-cell targeted therapies, treatment of resistant RA and measuring joint deterioration and disease progression. 

This meeting is approved for 5 CME credits by the Royal College of Physicians of Ireland.

Programme:

09:00  Registration

09:30 Welcome by Dr John Donohoe, President, Royal College of Physicians of Ireland

09:45 - 11:00

09:45: Prof Mary K Crow, Professor of Medicine and Immunology at Weill Medical College of Cornell University, New York, USA
Evolving Concepts in Therapeutics

10:15: Prof John Isaacs, Professor of Clinical Rheumatology, Director of Centre and Head of Clinical Rheumatology, Newcastle University, Newcastle-Upon-Tyne, UK
T-cell Targeted Therapies and Therapeutic Tolerance

11:15 - 12:30

11:15:  Prof Rene Westhovens, Professor, Department of Musculoskeletal and Sciences, Catholic University, Leuven, Belgium
Treating Resistant RA - New Therapeutics

11:45: Prof Harry Genant, Emeritus Professor of Radiology, Medicine, Epidemiology and Orthopaedic Surgery, University of California School of Medicine, San Francisco, USA
Measuring Joint Deterioration and Disease Progression 

1:30 - 2:00

1:30: Dr Michele Doran, Consultant Rheumatologist, St. James's Hospital, Dubiln, Ireland
How to Handle Biologics in Clinical Practice - Focus on Safety
2:00 Prof Laurence A. Rubin, Professor, Faculty of Medicine, University of Toronto, Canada
Evolving and Novel Options for the Treatment of Osteoporosis 

2:30 - 3:00 - Panel Discussion led by Prof Doug Veale
3:00 - 3:15 - Close of Session - Dr John Donohoe

The closing date for registration is 1st May 2008. Places are limited, so please book early

Download Registration Booklet

Register by Email